Answer
Nelarabine and ara-G have approximate plasma half-lives of 30 minutes and 3 hours, respectively, in patients with refractory leukaemia or lymphoma given nelarabine at 1,500 mg/m² (adults) or 650 mg/m² (paediatric patients).
Sources for this answer
- Atriance 5 mg/ml solution for infusionSandoz Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 19Document updated
Sources checked